Skip to content

Exagen Inc. XGN Total costs & expenses

Total costs & expenses at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$20.9M+42.5%
Janux Therapeutics logo
Janux TherapeuticsJANX
$37.95M+8.7%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$36.28M-10.7%
Quest Diagnostics logo
Quest DiagnosticsDGX
Agilent Technologies logo
Agilent TechnologiesA
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s total costs & expenses?
Exagen Inc. (XGN) reported total costs & expenses of $13.62M in Q1 2026.
How has Exagen Inc.'s total costs & expenses changed year-over-year?
Exagen Inc.'s total costs & expenses increased by 9.1% year-over-year, from $12.49M to $13.62M.
What is the long-term trend for Exagen Inc.'s total costs & expenses?
Over 4 years (2021 to 2025), Exagen Inc.'s total costs & expenses has grown at a -7.5% compound annual growth rate (CAGR), from $72.37M to $52.87M.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations during a specific period. It encompasses the cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure is essential for evaluating the company's overall cost structure and its ability to achieve operational leverage.